It’s hard to say if a mask is causing your lesions or if a mask is causing an irritation to your skin. If you’re having a flare, it’s important to talk with your doctor to determine the cause of your ...

SAN ANTONIO — Distinguishing between the various forms of cutaneous lupus can be challenging, even for experienced clinicians. If a patient presents with a malar rash — also known as a butterfly rash ...

Please provide your email address to receive an email when new articles are posted on . Black patients have a three- to five-fold increased incidence of primary chronic cutaneous lupus vs. white ...

This transcript has been edited for clarity. Matthew A. Sparks, MD: I'm Dr Matthew Sparks, and welcome to Medscape's InDiscussion podcast series on chronic kidney disease. Today we'll be discussing ...

A new study published in the Journal of Investigative Dermatology reports that half the skin lesions present in patients with lupus show the presence of viable staph bacteria. This makes them more ...

Lupus erythematosus is a heterogeneous autoimmune disorder that frequently manifests with distinctive cutaneous involvement. The cutaneous lesions, which range from a malar rash to more indurated, ...

Please provide your email address to receive an email when new articles are posted on . Victoria P. Werth, MD, professor of dermatology at the University of Pennsylvania Hospital, and chief of ...

The 15-44 age range of women faces elevated danger from this condition, which shows hereditary patterns because of both inherited factors and environmental elements which include sunlight exposure, ...

Systemic lupus erythematosus commonly presents as a rash. The rashes are caused by inflammation from the immune system fighting the body. Systemic lupus erythematosus, more commonly known as lupus, ...

May 10 is World Lupus Day. This is the day to spotlight the autoimmune disease, share stories of those fighting lupus and bring more attention to the condition, which is not widely known about. Stream ...

Three lupus patients in the UK have received ‘groundbreaking’ new treatment which could end the need for lifelong drugs. A new NHS trial is assessing the effectiveness of CAR T-cell therapy – ...